Wolchko J Scott
SEC CIK 1586893 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | Pres, CEO, Dir | 371.2K | — | $18.34M | 20 | 2021-07-22 | 2024-01-09 |
Most active insiders at FATE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Valamehr Bahram | Pres, CEO, Dir | — | $168.1K |
| 2 | TAHL CINDY | See Remarks | — | $154.7K |
| 3 | Adawi Kamal | CFO | — | — |
| 4 | Redmile Group, LLC | Dir, 10% | — | — |
| 5 | EPSTEIN ROBERT S | Dir | — | — |
| 6 | RASTETTER WILLIAM H | Dir | — | — |
Wolchko J Scott made no open-market trades at FATE in the last 12 months.
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-10 | 2024-01-09 | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | S - Sale | $4.37 | -14.4K | 371.2K | -4% | -$62.9K | |
| 2023-01-11 | 2023-01-10 | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | S - Sale | $5.24 | -45.9K | 385.6K | -11% | -$240.6K | |
| DM | 2022-07-25 | 2022-07-21+ | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $32.74 | -36.2K | 434.9K | -8% | -$1.19M |
| DM | 2022-07-25 | 2022-07-21+ | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.70 | +36.2K | 437.8K | +9% | +$97.9K |
| DM | 2022-04-25 | 2022-04-21+ | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $34.89 | -40.0K | 431.5K | -8% | -$1.40M |
| DM | 2022-04-25 | 2022-04-21+ | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.70 | +40.0K | 461.5K | +9% | +$108.0K |
| DA | 2022-02-04 | 2022-01-20 | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.70 | +30.0K | 461.5K | +7% | +$81.0K |
| DM | 2022-01-24 | 2022-01-20+ | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $39.66 | -40.0K | 431.5K | -8% | -$1.59M |
| DM | 2022-01-24 | 2022-01-20+ | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.72 | +40.0K | 461.5K | +9% | +$108.9K |
| M | 2022-01-13 | 2022-01-11 | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | S - Sale | $48.68 | -14.6K | 431.5K | -3% | -$709.0K |
| M | 2022-01-12 | 2022-01-10 | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | S - Sale | $46.86 | -34.2K | 446.1K | -7% | -$1.60M |
| D | 2021-11-22 | 2021-11-18 | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $54.27 | -20.0K | 393.8K | -5% | -$1.09M |
| D | 2021-11-22 | 2021-11-18 | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.70 | +20.0K | 413.8K | +5% | +$54.0K |
| D | 2021-11-22 | 2021-11-19 | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | A - Grant | $0.00 | +86.5K | 480.3K | +22% | $0 |
| DM | 2021-10-25 | 2021-10-21+ | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $59.55 | -60.0K | 393.8K | -13% | -$3.57M |
| DM | 2021-10-25 | 2021-10-21+ | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $2.89 | +60.0K | 423.8K | +16% | +$173.6K |
| D | 2021-08-20 | 2021-08-19 | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $4.84 | +20.0K | 413.8K | +5% | +$96.8K |
| D | 2021-08-20 | 2021-08-19 | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $88.01 | -20.0K | 393.8K | -5% | -$1.76M |
| DM | 2021-07-26 | 2021-07-22+ | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $85.66 | -60.0K | 417.2K | -13% | -$5.14M |
| DM | 2021-07-26 | 2021-07-22+ | FATE | FATE THERAPEUTICS INC | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $3.43 | +60.0K | 423.8K | +16% | +$206.0K |
Purchase Sale Sale after option exercise All abbreviations